|Articles|April 23, 2020

ERT Offers Patient-Administered ECG Assessment for Trials during COVID-19

ERT, a global data and technology company that captures endpoint data in clinical trials, has announced a partnership with AliveCor. The partnership enables ERT to capture digital cardiac safety data with KardiaMobile 6L.

To learn more about KardiaMobile 6L, click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

ERT Offers Patient-Administered ECG Assessment for Trials during COVID-19

Related Content

Introducing The Human Side of Clinical Trials

ACT Brief: RBQM Financial Value Quantification, Trial Budget Cost Visibility Gap, and GSK mRNA Flu Vaccine Phase III

Why Quantifying the Financial Value of RBQM Has Been So Hard—and What This Study Did Differently

From Perspective to Action: Addressing the Real Cost Pressures in Clinical Trial Budgeting

ACT Brief: Operating Model Change Before AI, Workforce Compression Through Integration, and Cevumeran Trial Termination

Trending on Applied Clinical Trials Online

Workforce Compression in AI-Driven Clinical Trial Operations

From Perspective to Action: Addressing the Real Cost Pressures in Clinical Trial Budgeting

Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First

Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology

ACT Brief: Site Cash Runway and Payment Infrastructure Priority, Biomarker Cut-Off Selection and Disparities, and Batch Failure Prevention Systems